In a patient who has reduced work hours to 80 hours per week but still has anxiety, depression, and occupational stress with adequate sleep, what are the recommended next steps, including pharmacologic treatment options?

Management of Persistent Anxiety, Depression, and Occupational Stress Despite Reduced Work Hours

For a patient still experiencing anxiety, depression, and occupational stress despite reducing to 80-hour work weeks with adequate sleep, initiate a combined approach of cognitive behavioral therapy (CBT) and pharmacotherapy with an SSRI or SNRI, while simultaneously addressing workplace factors through structured occupational health interventions.

Immediate Assessment and Risk Stratification

First, conduct formal symptom severity assessment using validated tools:

• PHQ-9 for depression (scores: 5-9 mild, 10-14 moderate, 15-19 moderately severe, ≥20 severe) 1
• GAD-7 for anxiety (scores: 5-9 mild, 10-14 moderate, ≥15 severe) 1
• HADS as alternative (score ≥8 on either subscale indicates caseness) 1

Critical safety step: Screen for suicidal ideation or risk of self-harm. If present, refer immediately for emergency psychiatric evaluation 1.

Rule out medical causes before proceeding: uncontrolled pain, fatigue, infection, electrolyte imbalances, or delirium 1.

Treatment Algorithm Based on Severity

For Moderate to Severe Symptoms (Most Likely Scenario)

Pharmacotherapy - First Line:

Start an SSRI or SNRI as first-line medication 1, 2. The choice should be based on:

• Side effect profile and tolerability
• Drug interactions with current medications
• Previous treatment response (if any)
• Patient age and medical comorbidities 1

Key principle: When anxiety and depression coexist (occurs in 50-60% of cases), treat the depression first 1. SSRIs/SNRIs effectively address both conditions 2, 3.

Avoid benzodiazepines for routine use due to abuse potential, dependence risk, and cognitive impairment. If used, limit strictly to short-term duration per psychiatric guidelines 1.

Concurrent Psychological Intervention

Initiate individual CBT delivered by a licensed mental health professional 1. This has the highest level of evidence among psychotherapies and achieves similar efficacy to antidepressants with moderate certainty of evidence 4.

CBT should include:

• Cognitive restructuring
• Behavioral activation
• Problem-solving strategies
• Stress reduction techniques
• Relapse prevention (particularly important as occupational stress is often chronic) 1

Critical point: The combination of medication and psychotherapy is preferred for severe depression and provides superior outcomes to either alone 5.

Addressing the Occupational Component

Despite reducing to 80 hours weekly, persistent symptoms indicate inadequate workplace modification. Implement structured occupational health interventions:

Immediate Workplace Adjustments:

• Adjusted duties to reduce high-stress responsibilities temporarily 6
• Scheduled follow-up occupational health consultations 6
• Workplace counseling referral 6

Address the Stress-Symptom Cycle:

The evidence shows occupational stress → depressive/anxiety symptoms → worsened occupational stress creates a self-perpetuating cycle 7, 8. Breaking this requires both symptom treatment AND workplace structural changes, not just individual coping strategies 9.

Common pitfall: Organizations often recommend individual stress management rather than organizational reforms 9. Push for actual workplace policy changes, not just personal resilience training.

Monitoring and Follow-Up Protocol

Monthly Assessment Until Symptom Resolution:

• Treatment adherence and side effects 1
• Symptom severity using same validated scales
• Functional impairment in work and personal life 1
• Satisfaction with treatment 1

Important caveat: Patients with anxiety often avoid follow-through on referrals due to avoidance behavior—a core feature of anxiety pathology 1. Proactive outreach is essential.

Treatment Adjustment Timeline:

At 8 weeks: If inadequate response despite good adherence, modify treatment 1:

• Add psychological intervention if only on medication
• Add pharmacotherapy if only in therapy
• Switch to different SSRI/SNRI
• Consider augmentation strategies (bupropion, buspirone, or aripiprazole) 4

Remission typically requires several months 3. Continue medications for 6-12 months after achieving remission 2.

Pharmacologic Options Summary

First-line: SSRIs or SNRIs 1, 2, 3

Augmentation if inadequate response:

• Bupropion SR (lower discontinuation rate than buspirone) 4
• Buspirone 4
• Aripiprazole (higher remission rates than bupropion in one trial) 4

Alternative agents:

• Pregabalin
• Tricyclic antidepressants (consider side effect profile)
• Moclobemide 2

Avoid: Routine benzodiazepine use beyond short-term crisis management 1, 2.

Key Warnings

• Warn patients about potential adverse effects and what symptoms warrant immediate contact 1
• Monitor for treatment-emergent suicidality, especially in younger patients
• Discontinuation increases relapse risk within first year—taper gradually while providing concurrent CBT 5
• Address comorbid substance use if present, as this predicts treatment failure 3

The evidence strongly supports that 80-hour work weeks, while reduced from higher levels, may still represent excessive occupational exposure requiring further workplace intervention alongside clinical treatment 6, 9.